Tenax Therapeutics Inc. (TENX)
NASDAQ · Healthcare
Tenax Therapeutics Inc. Shareholder Equity 2011–2025
Tenax Therapeutics Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Tenax Therapeutics Inc. shareholder equity as of December 31, 2025: 97.1M, a 5.52% increase year-over-year.
- Tenax Therapeutics Inc. shareholder equity for 2025 were 97.1M, a 5.52% increase from 2024.
- Tenax Therapeutics Inc. shareholder equity for 2024 were 92.0M, a 436.69% increase from 2016.
- Tenax Therapeutics Inc. shareholder equity for 2016 were 17.1M, a 75.66% decrease from 2015.
- Tenax Therapeutics Inc. shareholder equity for 2015 were 70.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Tenax Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $97 |
| 2024 | $92 |
| 2016 | $17 |
| 2015 | $70 |
| 2014 | $83 |
| 2013 | $-2 |
| 2012 | $-0 |
| 2011 | $-4 |
Tenax Therapeutics Inc. Shareholder Equity — FAQ
Tenax Therapeutics Inc. (TENX) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TENX's shareholder equity history?
The chart and table above show Tenax Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.